New imaging tool could predict brain tumor treatment success
NCT ID NCT06855628
First seen Nov 01, 2025 · Last updated Jun 11, 2026 · Updated 32 times
Summary
This study looks at whether a special type of imaging scan (DMI) can help predict how well a new drug (BPM31510) works in people with glioblastoma, an aggressive brain cancer. The study was planned for 10 participants but is currently on hold. The goal is to see if the scan can forecast how long patients live or when their disease gets worse.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Stanford University
Palo Alto, California, 94305, United States
Conditions
Explore the condition pages connected to this study.